Ehlers-Danlos Syndrome in NYC: An Integrative Approach to Managing Hypermobility and Pain

Ehlers-Danlos Syndrome (EDS) is a group of heritable connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. The most common subtype, hypermobile EDS (hEDS), affects an estimated 1 in 500 to 1 in 5,000 individuals — though experts believe significant underdiagnosis exists, particularly in women and in patients whose symptoms are attributed to anxiety, fibromyalgia, or unexplained musculoskeletal pain.

At Regen Health Physicians NYC, Dr. Ajit Dhaliwal sees a substantial number of patients who arrive carrying years of prior diagnoses that never fully explained their constellation of symptoms. EDS — and the closely related hypermobility spectrum disorder (HSD) — is frequently among the underlying drivers.

Understanding EDS: More Than Just "Being Flexible"

The connective tissue in EDS is qualitatively different. Mutations or dysregulation in collagen synthesis or collagen-interacting proteins result in tissue that is structurally weaker, more extensible, and less resilient under mechanical load.

The clinical consequences include:

• Joint instability and recurrent subluxation: Joints that shift partially out of position during ordinary movement, causing pain and micro-trauma
• Chronic musculoskeletal pain: Often migratory, poorly localized, and disproportionate to imaging findings
• Fatigue: Both central (neurological) and peripheral (musculoskeletal), often severe
• Dysautonomia: Frequently comorbid — including POTS (postural orthostatic tachycardia syndrome) — due to connective tissue laxity in vessel walls
• Gastrointestinal dysmotility: Delayed gastric emptying, SIBO, IBS-pattern symptoms
• Proprioceptive deficits: Impaired joint position sense contributes to falls, injury, and pain cycling
• Skin features: Easy bruising, velvet-like skin texture, striae unrelated to weight change

Many patients with EDS describe a diagnostic odyssey spanning a decade or more before receiving a correct diagnosis.

The Integrative Medicine Lens

Conventional medicine often manages EDS symptom by symptom — pain specialist for joints, gastroenterologist for GI motility, cardiologist for dysautonomia — without a unifying framework. The integrative approach at RHPNY treats the connective tissue dysregulation as the root system generating multiple symptom branches.

Pain Management Without Masking

Opiate-based pain management creates significant concerns in EDS patients: tolerance, hyperalgesia, and functional decline. RHPNY's approach to EDS pain prioritizes:

• PRP for unstable joints: Targeted intra-articular or periarticular PRP to promote fibrocartilage stability and reduce inflammatory signaling in chronically irritated joints
• Prolotherapy considerations: Sugar-water injections to stimulate local inflammatory healing in hypermobile ligaments and tendon insertions
• Low-dose naltrexone (LDN): Evidence-based use for central sensitization and pain modulation in connective tissue disorders
• BPC-157 peptide: Growing clinical interest in BPC-157 for tendon and ligament repair — a compelling consideration given EDS tendon fragility (see our peptide therapy services)

Addressing Dysautonomia and POTS

Many EDS patients have concurrent POTS. Dr. Dhaliwal's protocol for dysautonomia addresses:

• Volume expansion strategies (saline IV, high-sodium diet where appropriate)
• Compression garments
• Graded cardiovascular conditioning
• Hormonal contributors (especially low aldosterone and cortisol fluctuations)

GI Support

Leaky gut, SIBO, and motility disorders are common in EDS. Our chronic disease management approach includes gut microbiome assessment, motility support, and targeted nutritional interventions.

Nutrition and Connective Tissue Support

Collagen-supporting micronutrients — vitamin C (cofactor for collagen hydroxylation), magnesium, zinc, and specific amino acids — are often suboptimal in EDS patients. Personalized nutritional protocols are a core component of RHPNY's EDS program.

The Importance of a Coordinated Care Team

Dr. Dhaliwal does not operate in a silo. Complex EDS patients benefit from collaboration with:

• A physical therapist specializing in hypermobility (proprioception, stabilization focus)
• A psychologist familiar with chronic illness and central sensitization
• A neurologist or cardiologist for POTS management
• A genetics counselor for patients seeking diagnostic confirmation

RHPNY serves as the integrative hub, coordinating information and synthesizing it into a coherent, patient-specific protocol.

Is This You?

If you have been told your joints are "just loose," your pain is "all in your head," or you've received multiple diagnoses that partially but incompletely fit, a thorough integrative evaluation is warranted. Book a consultation with Dr. Dhaliwal at RHPNY. Our chronic disease management services and regenerative medicine for joints and pain are well suited to the complexity EDS presents.

Medical Disclaimer

This article is educational only. EDS management is individualized and complex. Treatment decisions should be made in partnership with a qualified physician familiar with connective tissue disorders. PRP and peptide therapies for EDS are not yet established as standard of care; patients should discuss the evidence, risks, and alternatives with their treating physician.